Cadila forays into US generics market

22-11-2013 Financial ExpressComments (0)

Cadila PharmaceuticalsGenerics

Ahmedabad-based Cadila Pharmaceuticals is foraying into the $350-billion US pharma market with its generic antiviral drug Acyclovir, which has been approved by the US Food and Drug Administration. Primarily a bulk drug supplier to the US market, the Rs ...

Read more on Financial Express

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top